POSC33 Value Contribution of Filgotinib for the Treatment of Moderate to Severe Rheumatoid Arthritis Using Multi-Criteria Decision Analysis (MCDA)
Abstract
Authors
A Arraiza E Casaus MÁ Fernández C González A López JL Poveda Q Pablo JL Trillo I Cuervo-Arango R Subirán X Badia